Primary Cell Culture Market Mechanical Separation Segment Is Expected To Witness A Lucrative CAGR Of 11.7% Till 2028, Owing To Advancements In…

According to a new report published by Grand View Research, the market growth can be primarily attributed to the increasing prevalence of chronic conditions, such as cancer, infections, autoimmune diseases, diabetes mellitus, cardiovascular diseases, and nephrological diseases. This has led to an increase in research, facilitating the high adoption of primary cell cultures.

Primary Cell Culture Industry Overview

The global primary cell culture market size was valued at USD 3.4 billion in 2020 and is expected to reach USD 8.0 billion by 2028, projecting to expand at a CAGR of 11.6% during forecast period.

The market growth can be primarily attributed to the increasing prevalence of chronic conditions, such as cancer, infections, autoimmune diseases, diabetes mellitus, cardiovascular diseases, and nephrological diseases. This has led to an increase in research, facilitating the high adoption of primary cell cultures.

Gather more insights about the market drivers, restrains and growth of the Global Primary Cell Culture Market

According to the American Cancer Society, there are an estimated 16.9 million cancer patients/survivors in 2020. According to the WHO (2020), 71.0 million people worldwide are suffering from chronic hepatitis C infection. Hence, the rising number of chronic disorders being diagnosed is driving the demand for research on advanced therapies, which is expected to boost the market growth in the coming years.

In addition, the rising usage of primary cell cultures for in-vitro testing and drug screening can be further attributed to the growth of the market for primary cell culture. These are derived from tissues, which facilitates researchers to study cellular structure in the in vivo state, showcasing their normal functioning. As a result, they are used as model systems to study cell biochemistry and physiology, aging processes, signaling studies, and metabolic processes, as well as the effect of toxic compounds and drugs.

COVID-19 pandemic is acting as a positive catalyst for the growth of the market for primary cell culture. Researchers are increasingly using primary cell culture for understanding the infection. Standardized and characterized epithelium cell culture models are facilitating the understanding of the physical barrier destroyed by the coronavirus. These models can help mimic the functions and properties of the respiratory tract, leading to a breakthrough for a research outcome turning into a medical application.

Moreover, the primary immune cell culture has been proven to be very beneficial in the study of immune repertoire to produce antibodies and antigens for the COVID-19 virus. As per the findings by the scientists from the German Primate Center in Gottingen, the COVID-19 virus could block the infection in lung cells with TMPRSS2, an inhibitor for serine protease. The results have been validated with the experiment using primary cell culture.

Primary Cell Culture Market Segmentation

Based On the Product Insights, the market is segmented into primary cells, reagents and supplements and media

Based On the Separation Methods Insights, the market is segmented into explant method, enzymatic degradation, mechanical separation and others

Based On the Cell Type Insights, the market is segmented into animal and human.

Based on the Application Insights, the market is segmented into tissue culture & tissue engineering, vaccine production, gene therapy and regenerative medicine, toxicity testing and drug screening, cancer research, model system, virology, prenatal diagnosis, stem cell therapy and others.

Based on the Regional Insights, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Browse through Grand View ResearchsBiotechnology IndustryResearch Reports.

Market Share Insights:

Key Companies Profile:

The companies are launching new and advanced products for primary cell culture. The new Gibco CTS OpTmizer Pro SFM helps in enhancing donor T (lymphocyte) cell proliferation. It is a new media solution for targeting the metabolism of healthy donors, for the efficient production of cost-effective cell therapies.

Some of the prominent players in the primary cell culture market include:

Order a free sample PDF of the Primary Cell Culture Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.

Web: https://www.grandviewresearch.com

Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist U.S.A.Email: Send EmailPhone: 1888202951Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United StatesCity: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/primary-cell-culture-market

Read the original post:
Primary Cell Culture Market Mechanical Separation Segment Is Expected To Witness A Lucrative CAGR Of 11.7% Till 2028, Owing To Advancements In...